Biotech · Private company · Research Triangle Park, NC, US
Eclipse Life Sciences, Inc.
Track this companyFree. Adds Eclipse Life Sciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Dexamethasone intravitreal implantPhase 2 · Diabetic Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
- EC-104 high dosePhase 2 · Diabetic Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
- EC-104 low dosePhase 2 · Diabetic Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- EC-104 Intravitreal Implant for the Treatment of Diabetic Macular EdemaPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Aug 19, 2024ClinicalTrials.gov NCT06536491 · fetched Nov 12, 2026
NIH awards1
- Mitochondrial-Targeted Therapy for Macular DegenerationFiscal year 2024 · $735.6KNIH RePORTER 5R44EY034732-02 · fetched Nov 12, 2026